| scholarly article | Q13442814 |
| P2093 | author name string | G Rudofsky | |
| C Wolfrum | |||
| L Stachorski | |||
| E Röder | |||
| B Meissburger | |||
| P2860 | cites work | Epac: A new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell | Q24619138 |
| CellProfiler: image analysis software for identifying and quantifying cell phenotypes | Q24676898 | ||
| A plasma kallikrein-dependent plasminogen cascade required for adipocyte differentiation | Q28357136 | ||
| Prevalence and trends in obesity among US adults, 1999-2008 | Q29547759 | ||
| Dynamics of fat cell turnover in humans | Q29615688 | ||
| Obesity prevalence from a European perspective: a systematic review | Q33340814 | ||
| Hypertrophy and/or Hyperplasia: Dynamics of Adipose Tissue Growth | Q33422940 | ||
| The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity | Q33786342 | ||
| Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance | Q33930808 | ||
| PPARs, Obesity, and Inflammation | Q34003196 | ||
| Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome | Q34116177 | ||
| Diet-induced obesity and reduced skin cancer susceptibility in matrix metalloproteinase 19-deficient mice | Q34346225 | ||
| Adipocyte differentiation: from fibroblast to endocrine cell | Q34462949 | ||
| A pericellular collagenase directs the 3-dimensional development of white adipose tissue | Q34522343 | ||
| Obesity and diabetes in the developing world--a growing challenge | Q34603178 | ||
| Developmental origin of fat: tracking obesity to its source. | Q34705822 | ||
| Role of Foxa-2 in adipocyte metabolism and differentiation | Q35169197 | ||
| Metalloproteases and adipogenesis: a weighty subject | Q35748020 | ||
| Stromelysin-1 regulates adipogenesis during mammary gland involution | Q36375815 | ||
| Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. | Q36765385 | ||
| The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance | Q37013929 | ||
| Hyperphagia and obesity in female mice lacking tissue inhibitor of metalloproteinase-1. | Q37136885 | ||
| Obesity, inflammation, and insulin resistance--a mini-review | Q37443544 | ||
| Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation | Q38358677 | ||
| The effect of insulin upon glucose metabolism by adipose cells of different size. Influence of cell lipid and protein content, age, and nutritional state | Q40325109 | ||
| Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation | Q40783644 | ||
| Metalloproteinase inhibition and erythroid potentiation are independent activities of tissue inhibitor of metalloproteinases-1. | Q41259344 | ||
| Regulation of collagen gene expression in 3T3-L1 cells. Effects of adipocyte differentiation and tumor necrosis factor alpha | Q42062650 | ||
| Proinflammatory adipocytokines induce TIMP-1 expression in 3T3-L1 adipocytes | Q42486453 | ||
| Enhanced synthesis and secretion of type IV collagen and entactin during adipose conversion of 3T3-L1 cells and production of unorthodox laminin complex. | Q42801668 | ||
| Tissue inhibitor of metalloproteinase-1 mRNA production and protein secretion are induced by interleukin-1 beta in 3T3-L1 adipocytes | Q42811356 | ||
| Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity | Q42817200 | ||
| Fibronectin modulation of cell shape and lipogenic gene expression in 3T3-adipocytes | Q42820082 | ||
| Protease inhibitor treatments reveal specific involvement of matrix metalloproteinase-9 in human adipocyte differentiation. | Q42823683 | ||
| Depot-specific differences in adipogenic progenitor abundance and proliferative response to high-fat diet | Q43297876 | ||
| Determination of adipocyte size by computer image analysis. | Q44007488 | ||
| In vitro reversal of hyperglycemia normalizes insulin action in fat cells from type 2 diabetes patients: is cellular insulin resistance caused by glucotoxicity in vivo? | Q44325219 | ||
| Adipocyte hypertrophy in stromelysin-3 deficient mice with nutritionally induced obesity | Q50196337 | ||
| Deficiency of tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) impairs nutritionally induced obesity in mice. | Q50320622 | ||
| Enhanced nutritionally induced adipose tissue development in mice with stromelysin-1 gene inactivation | Q50327229 | ||
| Subcutaneous abdominal preadipocyte differentiation in vitro inversely correlates with central obesity. | Q51032064 | ||
| Tissue inhibitor of metalloproteinase-1 predicts adiposity in humans. | Q51478765 | ||
| Fat cell enlargement is an independent marker of insulin resistance and 'hyperleptinaemia'. | Q51481213 | ||
| Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. | Q52540333 | ||
| Profiling of adipokines secreted from human subcutaneous adipose tissue in response to PPAR agonists | Q57420149 | ||
| Overexpression of tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) in mice does not affect adipogenesis or adipose tissue development | Q64377777 | ||
| Organization of extracellular matrix components during differentiation of adipocytes in long-term culture | Q73484321 | ||
| Characterization of the inhibitory effect of growth hormone on primary preadipocyte differentiation | Q77151236 | ||
| Matrix metalloproteinase inhibition impairs adipose tissue development in mice | Q77743242 | ||
| Adipokines oversecreted by omental adipose tissue in human obesity | Q80499731 | ||
| A functional role of gelatinase A in the development of nutritionally induced obesity in mice | Q81143818 | ||
| Stromelysin-3 is a potent negative regulator of adipogenesis participating to cancer cell-adipocyte interaction/crosstalk at the tumor invasive front | Q81562221 | ||
| P433 | issue | 6 | |
| P921 | main subject | adipogenesis | Q2824461 |
| obesity | Q12174 | ||
| P304 | page(s) | 1468-1479 | |
| P577 | publication date | 2011-03-25 | |
| P1433 | published in | Diabetologia | Q5270140 |
| P1476 | title | Tissue inhibitor of matrix metalloproteinase 1 (TIMP1) controls adipogenesis in obesity in mice and in humans | |
| P478 | volume | 54 |
| Q41108866 | Absence of Tissue Inhibitor of Metalloproteinase-4 (TIMP4) ameliorates high fat diet-induced obesity in mice due to defective lipid absorption |
| Q28505209 | Adipogenesis and insulin sensitivity in obesity are regulated by retinoid-related orphan receptor gamma |
| Q38204539 | Adipokines in gestational diabetes |
| Q37220627 | Assessment of neuroinflammation in a mouse model of obesity and β-amyloidosis using PET. |
| Q34341618 | Bi-directional interconversion of brite and white adipocytes |
| Q43170207 | CILAIR-Based Secretome Analysis of Obese Visceral and Subcutaneous Adipose Tissues Reveals Distinctive ECM Remodeling and Inflammation Mediators |
| Q45337492 | Connective tissue growth factor/CCN-2 is upregulated in epididymal and subcutaneous fat depots in a dietary-induced obesity model |
| Q49731832 | Differential expression of mRNA isoforms in the skeletal muscle of pigs with distinct growth and fatness profiles. |
| Q34726647 | Dynamic and extensive metabolic state-dependent regulation of cytokine expression and circulating levels |
| Q34948521 | Enamel matrix derivative inhibits adipocyte differentiation of 3T3-L1 cells via activation of TGF-βRI kinase activity |
| Q44324884 | Endocannabinoids regulate adipokine production and the immune balance of omental adipose tissue in human obesity. |
| Q52668530 | Exendin-4 modifies adipogenesis of human adipose-derived stromal cells isolated from omentum through multiple mechanisms. |
| Q50492021 | Genes involved in muscle lipid composition in 15 European Bos taurus breeds. |
| Q36098730 | Glucagon Like Peptide-1 Promotes Adipocyte Differentiation via the Wnt4 Mediated Sequestering of Beta-Catenin |
| Q35834766 | Improved adipose tissue metabolism after 5-year growth hormone replacement therapy in growth hormone deficient adults: The role of zinc-α2-glycoprotein |
| Q36279227 | Influence of diet on visceral adipose remodeling in NONcNZO10 mice with polygenic susceptibility for type 2 diabetes |
| Q90602682 | Liver ASK1 protects from non-alcoholic fatty liver disease and fibrosis |
| Q34171384 | Liver-specific expression of transcriptionally active SREBP-1c is associated with fatty liver and increased visceral fat mass |
| Q41045705 | Loss of Oncostatin M Signaling in Adipocytes Induces Insulin Resistance and Adipose Tissue Inflammation in Vivo |
| Q47389960 | Macrophages alter the differentiation-dependent decreases in fibronectin and collagen I/III protein levels in human preadipocytes. |
| Q36850318 | Matrix metalloproteinase 11 protects from diabesity and promotes metabolic switch |
| Q37993746 | Matrix metalloproteinases and their tissue inhibitors in hypertension-related pregnancy complications |
| Q48052597 | Naringenin interferes with the anti-diabetic actions of pioglitazone via pharmacodynamic interactions |
| Q30414585 | Naturally occurring HCA1 missense mutations result in loss of function: potential impact on lipid deposition |
| Q46119366 | PBMCs reflect the immune component of the WAT transcriptome--implications as biomarkers of metabolic health in the postprandial state |
| Q36595486 | Preventive obesity agent montmorillonite adsorbs dietary lipids and enhances lipid excretion from the digestive tract |
| Q48334300 | Proteomic analysis of the maternal protein restriction rat model for schizophrenia: identification of translational changes in hormonal signaling pathways and glutamate neurotransmission |
| Q42576974 | Regulation of adipocyte formation by GLP-1/GLP-1R signaling |
| Q28085224 | Revisiting the adipocyte: a model for integration of cytokine signaling in the regulation of energy metabolism |
| Q57225427 | Systemic inflammation in childhood obesity: circulating inflammatory mediators and activated CD14++ monocytes |
| Q36440108 | The α(1)AT and TIMP-1 Gene Polymorphism in the Development of Asthma |
| Q35689623 | Tissue Inhibitor Of Matrix Metalloproteinase-1 Is Required for High-Fat Diet-Induced Glucose Intolerance and Hepatic Steatosis in Mice |
| Q42827019 | Tissue inhibitor of metalloproteases-4 (TIMP-4) modulates adipocyte differentiation in vitro |
| Q37173360 | Transcriptional regulation of adipocyte formation by the liver receptor homologue 1 (Lrh1)-Small hetero-dimerization partner (Shp) network |
| Q37166760 | Transgenic overexpression of VEGF-C induces weight gain and insulin resistance in mice |
| Q36319849 | Transition into inflammatory cancer-associated adipocytes in breast cancer microenvironment requires microRNA regulatory mechanism |
| Q50698139 | [Expressions of inflammatory and fibrogenic factors in perinephric and subcutaneous adipose tissues of patients with adrenocorticotropic hormone-independent Cushing's syndrome]. |
Search more.